AZN vs MRK
AstraZeneca PLC · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | AZN | MRK |
|---|---|---|
| Price | $155.62 | $128.00 |
| Market Cap | $241.21B | $316.14B |
| P/E | 23.59 | 17.32 |
| P/B | 4.96 | 6.89 |
| P/S | 4.11 | 4.86 |
| ROE | 21.0% | 39.8% |
| Net Margin | 17.4% | 28.1% |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | 1.3% |
| Dividend Yield | 2.01% | 2.56% |
| EPS | $6.60 | $7.39 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.